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Abstract 
Tuberous sclerosis (TS) or Bourneville’s 
disease is a rare, multisystemic genetic 
disorder. It involves alterations to ectodermal 
and mesodermal cell differentiation and 
proliferation, causing benign hamartomatous 
tumors, neurofibromas and angiofibromas in 
the brain and other vital organs including the 
kidney, heart, eyes, lungs, skin and mucosa. 
It also affects the central nervous system and 
produces neurological dysfunctions such as 
seizures, mental retardation and behavior 
disorders. Tuberous (rootshaped) growths 
develop in the brain, and calcify over time, 
becoming hard and sclerotic, hence the name 
given to the disease. Although inheritance is 
autosomal dominant, 60-70% of cases occur 
through spontaneous mutations. The disease 
is related to some mutations or alterations in 
two genes, named TSC1 and TSC2. 
Discovered in 1997, TSC1 is located on 
chromosome 9q34 and produces a protein 
called hamartin. TSC2, discovered in 1993, is 
located on chromosome 16p13 and produces 
a protein called tuberin. The prevalence of 
the disease is 1/6000-10,000 live newborns, 
and it is estimated that there are 1-2 million 
sufferers worldwide. This paper presents a 
literature review and a family case report of a 
mother and two of her daughters with oral 
features of TS. 
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Introduction 
Tuberous sclerosis (TS) is a multisystemic 
genetic disorder classified as one of the 
phakomatoses (phakos – spot; oma - tumour) 
(1-4). The main characteristics of this disease 
are:  
(a) The disease inheritance is autosomal 
dominant. The probability to acquire the 
disease is 50% in children whose one of their 
progenitors carries the gene. 
(b) Symptoms exhibited by children with 
inherited TS may be milder or more severe 
that those of the parent affected (5). 
(c) The disease appears as a sporadic 
disorder. However, a new mutation can 
appear spontaneously. This occurs in 60-70% 
of the affected population. 
(d) Some individuals acquire TS through a 
process known as gonadal mosaicism. The 
parents of such patients do not present 
obvious defects in the two genes that cause 
the disorder. However, the parents may 
produce progenies suffering TS, because 
only some parental reproductive cells 
contained mutation and subsequently parents 
were both completely asymptomatic. When a 
gonadal mosaicism occurs,  a genetic test 
based on blood analysis is useless (5). 
Prenatal molecular diagnosis, which identifies 
many genetic diseases by analyzing the fetal 
DNA obtained through chorionic biopsy, 
amniocentesis or cordocentesis, is useful to 
detect TS.  A molecular diagnosis before the 
symptoms appear can also be performed to 
evaluate the expansion of the CAG 
trinucleotide in individuals at risk (5). 
 
Clinical signs 
1) Non oral and Systemic signs 
 
TS may affect any of the body’s systems, 
causing a wide range of signs and symptoms. 
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The natural course of the disease varies from 
one individual to another; also symptoms may 
range from very mild to extremely severe. 
Common symptoms include seizures in 80-
90% of cases (6), mental retardation, 
behavior disorders (high frequency of autism) 
and skin abnormalities. Benign tumors are 
common and may appear in any organ, 
although they are more frequent in the brain, 
kidneys, heart and skin. In contrast, malign 
tumors are rare; when existing, there is a 
tendency to affect the kidneys with renal cell 
carcinoma. The following features should be 
considered as particularly important: 
- Brain tumors: these can be of three types: 
cortical tubers, which usually appear on the 
surface of the brain, subependymal nodules 
located on the walls of the ventricles, and 
giant cell astrocytomas, which may block 
liquid flow within the brain and increase 
pressure, thus leading to cephaleas. 
- Neurological disorders: Between half and 
two-thirds of patients exhibited some type of 
epileptic seizure (tonic, tonic-clonic, partial 
myoclonic or generalized), infantile spasms 
with hypsarrhythmia (West’s syndrome) and 
mental disabilities ranging from mild learning 
difficulties to severe mental retardation. 
- Behavior problems: these include attention 
deficit and hyperactivity, obsessive-
compulsive disorder, sudden rage and even 
aggression.  
- Renal problems: angiomyolipomas, benign 
growths formed by fatty tissue and muscle 
cells. These tend to be bilateral and 
asymptomatic; however, they may reach a 
considerable size causing retroperitoneal 
bleeding, pain, weakness, severe anemia, 
reduced arterial pressure and renal failure. 
This is the primary cause of death among 
these patients (7). 
- Cardiac tumors: rhabdomyomas. When 
these tumors are large or multiple they may 
block the vessel circulation and cause death; 
this usually occurs immediately after delivery. 
- Eye lesions: benign tumors known as 
phakomas, appearing as whitish, mulberry-
like spots on the retina; generally they do not 
cause loss of vision. They are pathognomonic 
of this disease. Eyelid angiofibromas have 
also been described (8). 
- Dermatological signs: 1) hypomelanotic 
macules (“ash-leaf” spots), lighter in color 
than the skin and which may appear on any 
part of the body; 2) red marks or spots known 
as facial angiofibromas or Pringle’s 
sebaceous adenomas that appear on the 
face and are formed by blood vessels and 
fibrous tissue. They normally spread out 
symmetrically in the shape of butterfly wings 
in the nasogenian folds around the nose, 
cheeks and chin, and often cause facial 
disfiguration; 3) plaques on the forehead, in 
the form of raised and discolored areas; 4) 
small fleshy tumors known as fingernail 
angiofibromas (Koenen tumors) that grow 
around or under feet and hands' nails; 5) 
some areas where the skin has an orange-
peel texture (shagreen patch) are generally 
observed on the lower back. 
- Bone alterations: these are usually geodes 
1-3 mm in size of a pseudocystic nature, on 
metacarpal, metatarsal or phalangeal 
location, or alternatively areas of hyperostosis 
(1). 
2) Oral signs 
The incidence of oral lesions ranges from 11-
56% of patients (1,9). These usually take the 
form of fibromas located in the gums, 
mucosa, lips and base of the tongue. 
Enamel hypoplasia frequently appears in 
these patients, consisting of small pitted 
areas with an average size of 80 microns. 
They localize on the exposed face of the 
teeth and only affect the enamel, without 
damaging the dentine, and do not lead to 
caries (1,10). 
A single case of fibrous tumors in the 
maxillary bones has also been reported. 
Celenk and coworkers described a case in 
which there was a unique, hard and well-
circumscribed mass in the mandibular 
symphysis of a 15-year-old patient affected 
with TS classified as fibrolipomatous 
hamartoma (2). 
 
Diagnosis 
Diagnosis is based on careful clinical 
examination coupled with computerised 
tomography (TC) — very useful for detecting 
calcified tubers in the brain — and magnetic 
resonance (MR), which enables cortical 
tubers to be detected (1). 
Early diagnosis in very small children is 
carried out in the event of seizures 
convulsions (infantile spasms) at birth or the 
presence of cardiac rhabdomyomas. 
Prenatal diagnosis is also performed in 
patients at risk (5). 
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Case report 
 
The patients were a 69-year-old woman 
(C.A.G.), attending the dental clinic in a 
primary healthcare centre for a tooth 
extraction, and her 38 years old daughter 
(N.T.A.).. Their clinical histories revealed a 
diagnosis of TS and epilepsy, and both were 
previously treated with anti-convulsive drugs 
(phenytoin). No information on 
complementary tests was available whereas 
no toxic habits were reported. The medical 
history contained no other significant 
information. 
The history-taking and exploration revealed 
oligophrenia, attention deficit and 
hyperactivity in the mother, and moderate 
mental retardation in the daughter. 
The facial and body examination showed 
facial angiofibromas (Fig. 1) in both patients 
and fingernai angiofibromas (Koenen tumors) 
on feet and hands (Fig. 2), as well as a 
shagreen patch on the daughter. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. C.A.G. Facial angiofibromas. 
 
Examination of the mouth revealed poor oral 
hygiene, with chronic periodontitis, missing 
and displaced teeth, and a low caries index. 
Exploration of the mucosa showed, in the 
mother, multiple exophytic gum lesions, with 
a granulomatous appearance but without 
bleeding; they were the normal pink colour of 
the adjacent mucosa and were more frequent 
in the edentulous areas (Fig. 3). Similar 
lesions, although less widespread and raised, 
were observed on the cheek mucosa (Fig. 4). 
The daughter presented fewer lesions more 
spread on the oral mucosa. Both patients  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. C.A.G. Toenail angiofibromas. 
 
 
 
 
 
 
 
 
 
 
 
 
 
showed some lesions on the edges of the 
tongue and in the palate (Fig. 5). 
 
 
 
Figure 3. C.A.G. Exophytic lesions with a granulomatous 
appearance. 
 
The histopathological analysis of the mother’s 
biopsy revealed fibroepithelial hyperplasia, 
with profuse vascularisation, compatible with 
angiofibroma (Fig. 6). 
We could further examine another daughter 
(C.T.A.), aged 43 and also suffering TS and 
mild mental retardation. She showed almost 
identical oral manifestations: chronic 
periodontitis, missing and displaced teeth, 
and a low caries index. The exploration of 
skin and oral mucosa revealed fewer facial 
angiofibromas (she had undergone CO2 laser 
treatment on the skin), Koenen tumors and 
hypopigmentation; there were also widely  
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Figure 4. C.A.G. Exophytic lesions with a granulomatous 
appearance on the cheek mucosa. 
 
 
dispersed fibromas in the gum and cheek 
mucosa. 
Neurological examination of the three 
patients revealed normal cranial nerves, 
preserved strength, normal sensitivity, normal 
finger-nose and heel-knee coordination, 
except for the mother, who presented a 
staggering gait and a positive Romberg sign. 
Several imaging diagnostic tests were 
performed (cranial CT, head X-ray, oral 
panoramic scan, X-ray of wrists and hips) 
with the following results: 
- CT of the younger daughter: showed 
multiple cortical hamartomas, one of them 
calcified. Some alterations of the 
periventricular materia alba and 
subependymal nodules were detected; some 
of these were calcified, whereas the rest had 
clear appearance after endovenous contrast. 
- X-rays revealed various intra-medullar 
osteolytic areas in phalanges and 
irregularities in the metacarpal cortical area, 
increased bone density in the sacral region 
and areas of sclerosis with pedicles in the 
youngest patient, compatible with 
osteoblastic deposits. Head X-rays revealed 
calcifications in all three patients. In one 
patient, shown in Fig. 7, there was 
enlargement and increased density of both 
cranial tables, patches of sclerosis in the 
inner table, intracranial calcifications and an 
osteolytic image that was difficult to 
distinguish from the venous lacunae. The 
panoramic X-rays revealed no significant 
bone alterations, except for horizontal bone 
loss secondary to the periodontal disease in 
the three patients. 
The family history showed an increased 
incidence of the disease among female 
members (Fig. 8). 
  
 
Figure 5. N.T.A. Exophytic lesions with a granulomatous 
appearance. 
 
Discussion 
Only a few clinical cases of TS with oral 
clinical signs have been reported (1,2,9,11). It 
has been suggested that oral fibromas may 
not be truly TS lesions, but rather caused by 
the drugs used to treat the neurological 
disorders related to this disease (9). 
Hydantoins produce secondary gingival 
hypertrophy, when significant amounts of  
bacterial plaque is present (12,13). In a study 
by Lygidakis and coworkers oral fibromas 
were observed in 46% of ET patients, many 
of whom had never been treated with 
phenytoin or other anti-epileptic drugs (11). In 
addition, several studies have related 
hydantoin-induced hyperplasia to a range of 
factors including age and tobacco and alcohol 
consumption (14). Similar results were 
obtained by Thomason and coworkers, who 
argued that the likelihood of developing 
gingival hypertrophy was higher among 
children and adolescents than in adults. 
Thus, there would be an inverse relationship 
between age and gingival overgrowth (15).  
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Figure 6. N.T.A. Fibroepithelial hyperplasia showing 
vascular formations compatible with angiofibroma. 
 
 
Finally, Peñarrocha and coworkers argue that 
gingival overgrowth is a phenotypic 
presentation of the patient’s genetic 
response/susceptibility to the mitotic effect of 
phenytoin (16). 
Patients herein studied lack toxic habits; none 
of them exhibited significant gingival 
hyperplasia despite they were treated with 
anticonvulsants. In gingival hyperplasia 
induced by phenytoin administration gums 
appear pink and  homogenous whereas 
gingival lesions in TS appear as nipple-like, 
fibrous nodules often bleeding (9). This 
clinical finding was confirmed by histological 
data.  
Our patients´gingival health can be defined 
as chronic periodontitis enhanced by poor  
 
 
Regarding the presence of gingival fibromas, 
the oldest patient presented the largest and 
greatest number of nodules, as opposed to 
gingival overgrowth due to hydantoins as 
argued by Thomason y Gilman. This would  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. N.T.A. Enlargement and increased density of 
both cranial tables 
 
 
hygiene, and include typical TS-associated 
lesions in terms of the distribution, clustering, 
color and texture of the lesions. 
seem to support the hypothesis of gingival 
overgrowth as the patient’s genetic 
response/susceptibility to the mitotic effect of 
phenytoin, independent of the oral signs 
typically associated with TS. The importance 
of correct oral hygiene should be stressed in 
order to avoid risk factors that enhance 
periodontal disease of these patients. 
In summary, the patients described in the 
present work did not attend their dental 
appointment to assess the oral lesions 
associated with their base pathology but 
others. However, in our opinion, the dentist 
should  be aware of these kind of lesions, in 
order to better control them and to offer 
adequate advice for their treatment 
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Figure 8. Family tree. Patients studied: (TS): Tuberous sclerosis 
NC: No clinical features (genotype was not studied in these patients) 
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